Tweet
<img alt="" height="1" width="1" />
New Arthritis Drug Xeljanz Gets FDA Approval
WebMD
Nov. 6, 2012 -- The FDA has approved Pfizer's Xeljanz (tofacitinib), a first-of-its-kind treatment for rheumatoid arthritis. Xeljanz is approved for use by patients not helped by methotrexate, the usual first treatment for RA. It's a pill taken twice a day. Xeljanz is a ...
Pfizer Oral RA Drug Gets FDA ApprovalMedPage Today
News Summary: Pfizer rheumatoid arthritis drugThe Associated Press
Xeljanz, A Cheaper-But-Expensive $25000-A-Year Pfizer Pill For Rheumatoid ...Forbes
Reuters -RTT News -NASDAQ
all 223 news articles »
More...